Dr. Chika Anekwe is an obesity medicine physician at Harvard and debates the implications of using Ozempic for weight loss alongside Dr. Vinay Prasad, a hematologist-oncologist and policy expert. They delve into the controversy surrounding obesity as a disease versus a lifestyle choice. Meanwhile, Calley Means critiques industry practices and promotes healthier food policies. The trio tackles ethical dilemmas in pediatric obesity treatment and explores the effectiveness of Ozempic against deeper health issues, opening a lively discussion on our food and medical systems.